Addition of innovative drugs to the commercial insurance drug list, the official start of medical insurance catalog adjustment in 2025.

In 2025, the adjustment of the drug list for national basic medical insurance, maternity insurance, and work-related injury insurance, as well as the innovation drug list for commercial health insurance, officially began. Eligible applicants can submit their applications online through the National Medical Insurance Service Platform from July 11th to 20th. The newly added commercial insurance innovation drug list this year mainly focuses on drugs with high levels of innovation, significant clinical value, and significant benefits to patients. These drugs, which temporarily cannot be included in the basic list due to exceeding the "basic protection" positioning, aim to improve the multi-level drug guarantee system, better meet the diversified medication needs of the people, and provide more economic support for the development of innovative drugs.